{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T20:16:36Z","timestamp":1789676196852,"version":"4.0.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,5,13]],"date-time":"2020-05-13T00:00:00Z","timestamp":1589328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,5,13]],"date-time":"2020-05-13T00:00:00Z","timestamp":1589328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001381","name":"National Research Foundation Singapore","doi-asserted-by":"publisher","award":["NMRC\/CSAINV\/0017\/2017"],"award-info":[{"award-number":["NMRC\/CSAINV\/0017\/2017"]}],"id":[{"id":"10.13039\/501100001381","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001381","name":"National Research Foundation Singapore","doi-asserted-by":"publisher","award":["NMRC-CG-RIE 2020 - Project No.NMRC\/CG\/M003\/2017"],"award-info":[{"award-number":["NMRC-CG-RIE 2020 - Project No.NMRC\/CG\/M003\/2017"]}],"id":[{"id":"10.13039\/501100001381","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Familial Cancer"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1007\/s10689-020-00184-3","type":"journal-article","created":{"date-parts":[[2020,5,13]],"date-time":"2020-05-13T08:02:43Z","timestamp":1589356963000},"page":"353-358","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Biallelic NF1 inactivation in high grade serous ovarian cancers from patients with neurofibromatosis type 1"],"prefix":"10.1007","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1017-0372","authenticated-orcid":false,"given":"Eliza","family":"Courtney","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sock Hoai","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao Tzu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Ishak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khurshid","family":"Merchant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarryn","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen Yee","family":"Chay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felicia Hui Xian","family":"Chin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wai Loong","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adele","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Ngeow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,13]]},"reference":[{"key":"184_CR1","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/ajmg.a.33139","volume":"152A","author":"DG Evans","year":"2010","unstructured":"Evans DG, Howard E, Giblin C et al (2010) Birth incidence and prevalence of tumor-prone syndromes: estimates from a UK family genetic register service. Am J Med Genet Part A 152A:327\u2013332. https:\/\/doi.org\/10.1002\/ajmg.a.33139","journal-title":"Am J Med Genet Part A"},{"key":"184_CR2","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1038\/jid.2014.465","volume":"135","author":"E Uusitalo","year":"2015","unstructured":"Uusitalo E, Lepp\u00e4virta J, Koffert A et al (2015) Incidence and mortality of neurofibromatosis: a total population study in Finland. J Invest Dermatol 135:904\u2013906. https:\/\/doi.org\/10.1038\/jid.2014.465","journal-title":"J Invest Dermatol"},{"key":"184_CR3","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/B978-0-444-52902-2.00053-9","volume":"115","author":"RE Ferner","year":"2013","unstructured":"Ferner RE, Gutmann DH (2013) Neurofibromatosis type 1 (NF1): a diagnosis and management. Handb Clin Neurol 115:939\u2013955. https:\/\/doi.org\/10.1016\/B978-0-444-52902-2.00053-9","journal-title":"Handb Clin Neurol"},{"key":"184_CR4","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1093\/brain\/111.6.1355","volume":"111","author":"SM Huson","year":"1988","unstructured":"Huson SM, Harper PS, Compston DAS (1988) Von recklinghausen neurofibromatosis: a clinical and population study in south-east Wales. Brain 111:1355\u20131381. https:\/\/doi.org\/10.1093\/brain\/111.6.1355","journal-title":"Brain"},{"key":"184_CR5","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/S1474-4422(07)70075-3","volume":"6","author":"RE Ferner","year":"2007","unstructured":"Ferner RE (2007) Neurofibromatosis 1 and neurofibromatosis 2: a twenty first century perspective. Lancet Neurol 6:340\u2013351. https:\/\/doi.org\/10.1016\/S1474-4422(07)70075-3","journal-title":"Lancet Neurol"},{"key":"184_CR6","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.jpeds.2011.08.051","volume":"160","author":"CE Prada","year":"2012","unstructured":"Prada CE, Rangwala FA, Martin LJ et al (2012) Pediatric plexiform neurofibromas: impact on morbidity and mortality in neurofibromatosis type 1. J Pediatr 160:461\u2013467. https:\/\/doi.org\/10.1016\/j.jpeds.2011.08.051","journal-title":"J Pediatr"},{"key":"184_CR7","doi-asserted-by":"publisher","first-page":"571","DOI":"10.2223\/JPED.1718","volume":"83","author":"LG Darrigo","year":"2007","unstructured":"Darrigo LG, Geller M, Bonalumi Filho A, Azulay DR (2007) Preval\u00eancia de neurofibromas plexiformes em crian\u00e7as e adolescentes com neurofibromatose tipo 1. J Pediatr (Rio J) 83:571\u2013573. https:\/\/doi.org\/10.2223\/JPED.1718","journal-title":"J Pediatr (Rio J)"},{"key":"184_CR8","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1002\/(SICI)1096-8628(19970516)70:2<138::AID-AJMG7>3.0.CO;2-U","volume":"70","author":"JM Friedman","year":"1997","unstructured":"Friedman JM, Birch PH (1997) Type 1 neurofibromatosis: a descriptive analysis of the disorder in 1728 patients. Am J Med Genet 70:138\u2013143","journal-title":"Am J Med Genet"},{"key":"184_CR9","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1177\/088307389300800421","volume":"8","author":"K North","year":"1993","unstructured":"North K (1993) Neurofibromatosis type 1: Review of the first 200 patients in an Australian clinic. J Child Neurol 8:395\u2013402. https:\/\/doi.org\/10.1177\/088307389300800421","journal-title":"J Child Neurol"},{"key":"184_CR10","doi-asserted-by":"publisher","first-page":"e35711","DOI":"10.1371\/journal.pone.0035711","volume":"7","author":"SR Plotkin","year":"2012","unstructured":"Plotkin SR, Bredella MA, Cai W et al (2012) Quantitative assessment of whole-body tumor burden in adult patients with neurofibromatosis. PLoS One 7:e35711. https:\/\/doi.org\/10.1371\/journal.pone.0035711","journal-title":"PLoS One"},{"key":"184_CR11","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.jpeds.2011.04.008","volume":"159","author":"R Nguyen","year":"2011","unstructured":"Nguyen R, Kluwe L, Fuensterer C et al (2011) Plexiform neurofibromas in children with neurofibromatosis type 1: frequency and associated clinical deficits. J Pediatr 159:652\u2013655. https:\/\/doi.org\/10.1016\/j.jpeds.2011.04.008","journal-title":"J Pediatr"},{"key":"184_CR12","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1215\/15228517-2008-011","volume":"10","author":"V-F Mautner","year":"2008","unstructured":"Mautner V-F, Asuagbor FA, Dombi E et al (2008) Assessment of benign tumor burden by whole-body MRI in patients with neurofibromatosis 1. Neuro Oncol 10:593\u2013598. https:\/\/doi.org\/10.1215\/15228517-2008-011","journal-title":"Neuro Oncol"},{"key":"184_CR13","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1212\/wnl.50.6.1755","volume":"50","author":"JH Tonsgard","year":"1998","unstructured":"Tonsgard JH, Kwak SM, Short MP, Dachman AH (1998) CT imaging in adults with neurofibromatosis-1: frequent asymptomatic plexiform lesions. Neurology 50:1755\u20131760. https:\/\/doi.org\/10.1212\/wnl.50.6.1755","journal-title":"Neurology"},{"key":"184_CR14","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1136\/jmg.39.5.311","volume":"39","author":"DGR Evans","year":"2002","unstructured":"Evans DGR, Baser ME, McGaughran J et al (2002) Malignant peripheral nerve sheath tumours in neurofibromatosis 1. J Med Genet 39:311\u2013314. https:\/\/doi.org\/10.1136\/jmg.39.5.311","journal-title":"J Med Genet"},{"key":"184_CR15","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1200\/JCO.2015.65.3576","volume":"34","author":"E Uusitalo","year":"2016","unstructured":"Uusitalo E, Rantanen M, Kallionp\u00e4\u00e4 RA et al (2016) Distinctive cancer associations in patients with neurofibromatosis type 1. J Clin Oncol 34:1978\u20131986. https:\/\/doi.org\/10.1200\/JCO.2015.65.3576","journal-title":"J Clin Oncol"},{"key":"184_CR16","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/2045-3329-2-17","volume":"2","author":"DGR Evans","year":"2012","unstructured":"Evans DGR, Huson SM, Birch JM (2012) Malignant peripheral nerve sheath tumours in inherited disease. Clin Sarcoma Res 2:17. https:\/\/doi.org\/10.1186\/2045-3329-2-17","journal-title":"Clin Sarcoma Res"},{"key":"184_CR17","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1007\/s00381-009-1024-2","volume":"26","author":"A Rosenfeld","year":"2010","unstructured":"Rosenfeld A, Listernick R, Charrow J, Goldman S (2010) Neurofibromatosis type 1 and high-grade tumors of the central nervous system. Child\u2019s Nerv Syst 26:663\u2013667. https:\/\/doi.org\/10.1007\/s00381-009-1024-2","journal-title":"Child\u2019s Nerv Syst"},{"key":"184_CR18","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S0022-3476(94)70122-9","volume":"125","author":"R Listernick","year":"1994","unstructured":"Listernick R, Charrow J, Greenwald M, Mets M (1994) Natural history of optic pathway tumors in children with neurofibromatosis type 1: a longitudinal study. J Pediatr 125:63\u201366. https:\/\/doi.org\/10.1016\/S0022-3476(94)70122-9","journal-title":"J Pediatr"},{"key":"184_CR19","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1097\/NEN.0b013e318165eb75","volume":"67","author":"FJ Rodriguez","year":"2008","unstructured":"Rodriguez FJ, Perry A, Gutmann DH et al (2008) Gliomas in neurofibromatosis type 1: a clinicopathologic study of 100 patients. J Neuropathol Exp Neurol 67:240\u2013249. https:\/\/doi.org\/10.1097\/NEN.0b013e318165eb75","journal-title":"J Neuropathol Exp Neurol"},{"key":"184_CR20","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/0092-8674(90)90024-9","volume":"62","author":"G Xu","year":"1990","unstructured":"Xu G, O\u2019Connell P, Viskochil D et al (1990) The neurofibromatosis type 1 gene encodes a protein related to GAP. Cell 62:599\u2013608. https:\/\/doi.org\/10.1016\/0092-8674(90)90024-9","journal-title":"Cell"},{"key":"184_CR21","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s40246-017-0109-3","volume":"11","author":"C Philpott","year":"2017","unstructured":"Philpott C, Tovell H, Frayling IM et al (2017) The NF1 somatic mutational landscape in sporadic human cancers. Hum Genomics 11:13. https:\/\/doi.org\/10.1186\/s40246-017-0109-3","journal-title":"Hum Genomics"},{"key":"184_CR22","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.gore.2018.01.005","volume":"23","author":"EJ Norris","year":"2018","unstructured":"Norris EJ, Jones WD, Surleac MD et al (2018) Clonal lineage of high grade serous ovarian cancer in a patient with neurofibromatosis type 1. Gynecol Oncol Reports 23:41\u201344. https:\/\/doi.org\/10.1016\/j.gore.2018.01.005","journal-title":"Gynecol Oncol Reports"},{"key":"184_CR23","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/sj.bjc.6603227","volume":"95","author":"L Walker","year":"2006","unstructured":"Walker L, Thompson D, Easton D et al (2006) A prospective study of neurofibromatosis type 1 cancer incidence in the UK. Br J Cancer 95:233\u2013238. https:\/\/doi.org\/10.1038\/sj.bjc.6603227","journal-title":"Br J Cancer"},{"key":"184_CR24","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S et al (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med Off J Am Coll Med Genet 17:405\u2013424. https:\/\/doi.org\/10.1038\/gim.2015.30","journal-title":"Genet Med Off J Am Coll Med Genet"},{"key":"184_CR25","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1038\/ejhg.2011.113","volume":"19","author":"DGR Evans","year":"2011","unstructured":"Evans DGR, O\u2019Hara C, Wilding A et al (2011) Mortality in neurofibromatosis 1: In North West England: An assessment of actuarial survival in a region of the UK since 1989. Eur J Hum Genet 19:1187\u20131191. https:\/\/doi.org\/10.1038\/ejhg.2011.113","journal-title":"Eur J Hum Genet"},{"key":"184_CR26","doi-asserted-by":"publisher","first-page":"3156","DOI":"10.1038\/ncomms4156","volume":"5","author":"KL Kanchi","year":"2014","unstructured":"Kanchi KL, Johnson KJ, Lu C et al (2014) Integrated analysis of germline and somatic variants in ovarian cancer. Nat Commun 5:3156. https:\/\/doi.org\/10.1038\/ncomms4156","journal-title":"Nat Commun"},{"key":"184_CR27","first-page":"138","volume":"96","author":"A Salud","year":"1991","unstructured":"Salud A, Porcel J, Capdevila F et al (1991) [Ovarian cancer in a female patient with von Recklinghausen\u2019s disease]. - PubMed - NCBI. Med Clin (Barc) 96:138\u2013140","journal-title":"Med Clin (Barc)"},{"key":"184_CR28","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1006\/gyno.2002.6757","volume":"86","author":"M Ceccaroni","year":"2002","unstructured":"Ceccaroni M, Genuardi M, Legge F et al (2002) BRCA1-related malignancies in a family presenting with von Recklinghausen\u2019s Disease. Gynecol Oncol 86:375\u2013378. https:\/\/doi.org\/10.1006\/gyno.2002.6757","journal-title":"Gynecol Oncol"},{"key":"184_CR29","doi-asserted-by":"publisher","first-page":"5014","DOI":"10.1038\/s41467-018-07452-y","volume":"9","author":"J-P Brosseau","year":"2018","unstructured":"Brosseau J-P, Liao C-P, Wang Y et al (2018) NF1 heterozygosity fosters de novo tumorigenesis but impairs malignant transformation. Nat Commun 9:5014. https:\/\/doi.org\/10.1038\/s41467-018-07452-y","journal-title":"Nat Commun"},{"key":"184_CR30","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1593\/neo.08784","volume":"10","author":"N Sangha","year":"2008","unstructured":"Sangha N, Wu R, Kuick R et al (2008) Neurofibromin 1 (NF1) defects are common in human ovarian Serous Carcinomas and co-occur with TP53 mutations. Neoplasia 10:1362\u20131372. https:\/\/doi.org\/10.1593\/neo.08784","journal-title":"Neoplasia"}],"container-title":["Familial Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-020-00184-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10689-020-00184-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-020-00184-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,12]],"date-time":"2021-05-12T23:16:22Z","timestamp":1620861382000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10689-020-00184-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,13]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["184"],"URL":"https:\/\/doi.org\/10.1007\/s10689-020-00184-3","relation":{},"ISSN":["1389-9600","1573-7292"],"issn-type":[{"value":"1389-9600","type":"print"},{"value":"1573-7292","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,13]]},"assertion":[{"value":"13 May 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"J.N. received funding from AstraZeneca for breast and ovarian cancer research. The remaining authors have no conflict of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The research was approved by the SingHealth Centralised Institutional Review Board (CIRB number is 2011\/826\/B) and was performed in accordance with the Helsinki Declaration of 1975, as revised in 2000. Written informed consent for research was obtained from both patients.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}